GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
3 hedge funds and large institutions have $29K invested in GeoVax Labs Warrants in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
24% less capital invested
Capital invested by funds: $38K → $29K (-$9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$7K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.94K |
GOVXW Hedge Fund Activity: Q3 2022 in Review
3 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q3 2022, worth a combined $29K — down 24% from $38K a quarter earlier.
Fund positioning in GOVXW was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14.4K. The largest seller was Clear Street, exiting entirely with an estimated $7K sold.
- 3 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $29K of GeoVax Labs Warrants stock for Q3 2022, down 24% quarter-over-quarter.
- 1 fund opened new GeoVax Labs Warrants positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest GeoVax Labs Warrants buyer in Q3 2022 was Susquehanna International Group, an estimated $14.4K added.
- The largest GeoVax Labs Warrants seller in Q3 2022 was Clear Street, an estimated $7K sold.
Based on aggregated 13F filings for Q3 2022.